Drug maker tracks pregnant patients to check baby safety
NCT ID NCT06258902
Summary
This study aims to learn about the safety of the drug odevixibat during pregnancy and breastfeeding. It will observe about 20 people who took the drug while pregnant or nursing, collecting information from their regular medical records. The goal is to see if the drug is linked to any birth defects or other problems for the baby or mother.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY RELATED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Virtual Research Coordination Center Odevixibat (BYLVAY) Pregnancy Surveillance Program
RECRUITINGWilmington, North Carolina, 28401, United States
Conditions
Explore the condition pages connected to this study.